Results 21 to 30 of about 13,758 (132)

High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy. [PDF]

PLoS ONE, 2014
BACKGROUND: Myocardial scarring can be assessed by cardiac magnetic resonance imaging with late gadolinium enhancement and by endomyocardial biopsy.
Tetsuo Konno, Kenshi Hayashi, Noboru Fujino, Yoji Nagata, Akihiko Hodatsu, Eiichi Masuta, Kenji Sakata, Hiroyuki Nakamura, Masa-aki Kawashiri, Masakazu Yamagishi   +9 more
doaj   +1 more source

Endomyocardial biopsy using the brachial venous access route. Description of the technique and 12-year experience at 2 different centers

REC: Interventional Cardiology (English Ed.), 2020
Introduction and objectives: Recipients of a heart transplant need to receive serial endomyocardial biopsies (EMB) to discard rejection, a procedure that is usually performed through the femoral or jugular vein. Over the last few years, we have developed
María Tamargo, Enrique Gutiérrez Ibañes, Juan Francisco Oteo Domínguez, Felipe Díez-Delhoyo, Ebrey León Aliz, Ricardo Sanz Ruiz, Francisco José Hernández Pérez, María Eugenia Vázquez Álvarez, Javier Segovia Cubero, Allan Rivera Juárez, Eduardo Zataraín, Javier Goicolea Ruigómez, Javier Soriano, Elena Pérez Pereira, Jorge García-Carreño, Arturo García Touchard, Lilian Grigorian, José Antonio Fernández Díaz, Jaime Elízaga, Luis Alonso Pulpó, Francisco Fernández-Avilés   +20 more
doaj   +1 more source

ENDOMYOCARDIAL BIOPSY–A NOVEL TECHNIQUE THROUGH FEMORAL APPROACH

Pakistan Armed Forces Medical Journal, 2016
The technique of Endomyocardial biopsy was first described in 19741. It is an established invasive clinical tool used for surveillance of cardiac allograft rejection and, to a lesser extent, in the evaluation of dilated and restrictive ...
Muhammad Nadir Khan, Usman Iqbal
doaj   +2 more sources

Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy. [PDF]

PLoS ONE, 2016
Risk stratification of patients with non-ischemic dilated cardiomyopathy remains a matter of debate in the era of device implantation.We investigated associations between histopathological findings, contrast-enhanced cardiac MRI and the inducibility of ...
Karin A L Mueller, Christian Heck, David Heinzmann, Johannes Schwille, Karin Klingel, Reinhard Kandolf, Ulrich Kramer, Michael Gramlich, Tobias Geisler, Meinrad P Gawaz, Juergen Schreieck, Peter Seizer   +11 more
doaj   +1 more source

Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis

ESC Heart Failure, Volume 12, Issue 2, Page 809-818, April 2025.
Abstract Aims This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light‐chain amyloidosis (AL) and hereditary (ATTRv) and wild‐type transthyretin amyloidosis (ATTRwt)].
Alessia Argirò, Mattia Zampieri, Carlotta Mazzoni, Carlo Fumagalli, Michela Baccini, Alessandra Mattei, Alberto Cipriani, Laura De Michieli, Aldostefano Porcari, Gianfranco Sinagra, Marco Merlo, Giacomo Tini, Beatrice Musumeci, Domitilla Russo, Pier Filippo Vianello, Marco Canepa, Roberto Licordari, Gianluca di Bella, Claudio Rapezzi, Federico Perfetto, Francesco Cappelli   +20 more
wiley   +1 more source

Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal model

Journal of Cardiovascular Magnetic Resonance, 2010
Background Because Endomyocardial Biopsy has low sensitivity of about 20%, it can be performed near to myocardium that presented as Late Gadolinium Enhancement (LGE) in cardiovascular magnetic resonance (CMR).
Korkusuz Huedayi, Esters Philip, Huebner Frank, Bug Reinhold, Ackermann Hanns, Vogl Thomas J   +5 more
doaj   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Targeted treatment in viral‐associated inflammatory cardiomyopathy

Clinical Case Reports, 2021
Detection of viruses like HHV‐6 in endomyocardial biopsy or serum serology of patients with myocarditis or heart failure features unresponsive to conventional heart failure therapies could be a potential targeted treatment especially in refractory cases.
Ahmad Amin, Sepideh Taghavi, Maryam Chenaghlou, Elahe Zare, Monireh Kamali, Nasim Naderi   +5 more
doaj   +1 more source

Old disease, new twist

Journal of Hospital Medicine, EarlyView.
Abstract An 81‐year‐old man with a history of high‐grade urothelial carcinoma of the bladder and ureter on treatment with atezolizumab and tiragolumab presented to the emergency department with 5 months of malaise, generalized weakness, and fatigue and 2 weeks of subjective fevers. One month prior to presentation, he received an empiric 9‐day course of
Hadi Roudsari, Gurpreet Dhaliwal, Anand D. Jagannath, Alan H. Baik, Sam Brondfield   +4 more
wiley   +1 more source

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes, Florian Buehning, Tobias Lerchner, Julia Vogel, Raluca I. Mincu, Matthias Totzeck, Tienush Rassaf, Lars Michel   +7 more
wiley   +1 more source